29 Jan 2020

European Medicines Agency ranks animal antibiotics and appropriate ways to use them to protect public health

EMA has been instrumental in bringing together experts from around the EU to create an efficient and robust system for the evaluation and supervision of human and veterinary medicines that serves citizens throughout the region by using a One Health approach to promote integrated cooperation between human and veterinary medicines. Veterinarians across the EU have been advised to consult the infographic when deciding what antibiotics to prescribe to animals.

23 Jan 2020

Increasing antimicrobial resistace awareness through community converations


In Ethiopia, improved access to veterinary drugs has led to their increasing use in food-producing animals. The animal health extension service that ought to educate and advise community members about integrated animal health management strategies is limited. Community members, including livestock keepers, have limited access to animal health education, advisory and training services. Livestock keepers often buy veterinary drugs from roadside markets and self-treat their animals without considering the consequences of administering these drugs themselves. Most of these small-scale farmers have limited knowledge of the link between misuse of veterinary drugs and the emergence of antimicrobial resistance (AMR), which results in treatment failures in animals and humans. To address this knowledge and information gap, the CGIAR Research Program on Livestock in Ethiopia tested a community-based animal health extension approach using ‘community conversations’ to engage community members and local service providers in collaborative learning and joint action processes to increase AMR awareness. 

8 Jan 2020

Newly appointed head of CGIAR AMR Hub, Arshnee Moodley

CGIAR AMR Hub is pleased to welcome Arshnee Moodley, an associate professor from the University of Copenhagen in Denmark to lead the CGIAR AMR Hub hosted and led by ILRI. Having completed her undergraduate degree in 2002 from the University of Witwatersrand, South Africa and received her PhD from the University of Copenhagen, Denmark in 2008, she has spent 12 years supervising and teaching students at the University of Copenhagen on infection microbiology, antimicrobial resistance, bacterial typing and non-antibiotic alternatives. ILRI’s bioscience writer, Ekta Patel caught up with her on some quick Q&A’s to get to know her a little better and to better understand her vision for the CGIAR AMR Hub. 


The CGIAR Antimicrobial Resistance Hub, led by the International Livestock Research Institute (ILRI), applies a One Health approach to support the efforts of low- and middle-income countries (LMICs) in controlling agriculture-associated AMR risks, through promoting and facilitating transdisciplinary partnerships.

The recently adopted CGIAR AMR strategy recognizes the need for evidence on links between agriculture (crops, livestock and aquaculture) and public health outcomes. Based on evidence generated, the hub develops solutions that are locally relevant and applicable, while being adaptable to other contexts.

Read More

Our Approach

We conduct context-driven and systems-oriented research that combines social and biological sciences. With AMR research in agriculture and aquaculture and understanding linkages to public health outcomes, we can reap solutions emerging from our transdisciplinary approach.
We aim to reduce and refine AMU in agriculture and aquaculture and its impact on the environment, and to facilitate evidence-based communication around agriculture-associated AMR. This will help to mitigate AMR risks for people and contributes to improving the sustainability of global food and health systems.
The implementation framework of our strategy is organized into five pillars.

Contribution to the SDGs

Judiciously addressing antimicrobial resistance is especially important in low- and middle-income countries, where poverty exacerbates cycles of inequity

Tackling antimicrobial resistance helps sustain small-scale agriculture and aquaculture and improve poor people’s access to nourishing food

Particularly in poorer countries already facing a high disease burden, antimicrobial resistance increases the likelihood that medical and veterinary treatments will fail 

The problem of antimicrobial resistance can exacerbate gender inequality by increasing the risks faced by female primary caregivers of contracting antimicrobial-resistant infections

Over- and misuse of antibiotics and other antimicrobial drugs can contaminate soil and water resources, endangering people’s access to safe drinking water

It has been estimated that if not stemmed, antimicrobial resistance could cost the global economy up to USD100 trillion by 2050

Rational use of antibiotics and other antimicrobial drugs in good animal and fish husbandry practices is key to safeguarding the longer-term effectiveness of these important drugs

Only large networks of interdisciplinary partnerships and collaborators will be able to meet the many challenges presented by the growing development of antimicrobial resistance